Inc., the fast-growing developer of the world's only hemodynamic
transesophageal echocardiography (hTEE™)
management device, announced the second and third symposia in a planned
series of academic events presenting hTEE clinical evidence. These
additions to ImaCor's 2013 educational program focus on hTEE management
of trauma and cardiothoracic patients.
Trauma Symposium will take place this Friday,
January 18th from 1:30-3:15 PM at the JW Marriott Camelback
Inn in Scottsdale, Arizona during the 26th Annual Scientific
Assembly of the Eastern Association for the Surgery of Trauma (EAST).
Faculty for the event include:
Cardiac Support Symposium is scheduled for Monday, January 28th
from 6:00-7:15 AM at the JW Marriott Los Angeles LA LIVE Hotel during
the Society of Thoracic Surgeons (STS)
49th Annual Meeting. At this symposium concentrating on the
hemodynamic management of high-acuity cardiac surgical patients,
is the only technology in critical care that provides continuously
available direct cardiac visualization. hTEE management improves patient
outcomes, can shorten length of stay, and reduces intensive care cost.
The established hTEE management program includes a proven Clinical
Training Pathway for intensivists.
ImaCor Inc. is a privately held company headquartered in Garden
City, NY. The company designs, manufactures, and distributes advanced
solutions for hemodynamic assessment in the critical care environment
for the purpose of improving patient outcomes and optimizing utilization
of healthcare resources. ImaCor manufactures the ClariTEE® probe, the
only miniaturized, indwelling TEE probe suitable for long-term clinical
settings. hTEE™, Zura™, Zura EVO™, Adaptaflex™, and ClariTEE® are
trademarks of ImaCor, Inc. For more information, please visit our
website at www.imacorinc.com.
[ Back To NFVZone's Homepage ]